{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:52:50Z","timestamp":1790358770590,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007175","name":"Conseil National de la Recherche Scientifique","doi-asserted-by":"publisher","award":["RB3-SLD"],"award-info":[{"award-number":["RB3-SLD"]}],"id":[{"id":"10.13039\/501100007175","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473782"],"award-info":[{"award-number":["82473782"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["2025ZNSFSC1869"],"award-info":[{"award-number":["2025ZNSFSC1869"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004912","name":"Sichuan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013365","name":"West China Hospital, Sichuan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013365","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2022YFC2303700"],"award-info":[{"award-number":["2022YFC2303700"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014580","name":"Centro de Ecol\u00f3gia Aplicada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014580","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ejmech.2025.118288","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T07:51:49Z","timestamp":1761637909000},"page":"118288","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"P1","title":["Structure-guided design of potent tetrazolo[1,5-a]pyrimidine-based tubulin inhibitors with in vivo antitumor activity"],"prefix":"10.1016","volume":"302","author":[{"given":"Yaolin","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanwei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuiyu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengyong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lun","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruofei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiping","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.118288_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102063","article-title":"A novel tubulin inhibitor, 6h, suppresses tumor-associated angiogenesis and shows potent antitumor activity against non-small cell lung cancers","volume":"298","author":"Liu","year":"2022","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.118288_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116649","article-title":"Discovery and mechanistic insights into thieno[3,2-d]pyrimidine and heterocyclic fused pyrimidines inhibitors targeting tubulin for cancer therapy","volume":"276","author":"Wu","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118288_bib3","doi-asserted-by":"crossref","first-page":"6697","DOI":"10.1021\/acs.jmedchem.3c00011","article-title":"X-ray crystal structure-guided discovery of novel indole analogues as colchicine-binding site tubulin inhibitors with immune-potentiating and antitumor effects against melanoma","volume":"66","author":"Ren","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118288_bib4","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/s41580-021-00399-x","article-title":"Regulation of microtubule dynamics, mechanics and function through the growing tip","volume":"22","author":"Gudimchuk","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2025.118288_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2020.100742","article-title":"Taxanes in cancer treatment: activity, chemoresistance and its overcoming","volume":"54","author":"Mosca","year":"2021","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.ejmech.2025.118288_bib6","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ijpharm.2017.05.016","article-title":"Paclitaxel: what has been done and the challenges remain ahead","volume":"526","author":"Bernabeu","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejmech.2025.118288_bib7","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1111\/IGC.0b013e3181a38e2f","article-title":"Abraxane for the treatment of gynecologic cancer patients with severe hypersensitivity reactions to paclitaxel","volume":"19","author":"Fader","year":"2009","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ejmech.2025.118288_bib8","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.biopha.2017.10.041","article-title":"New insights into vinca alkaloids resistance mechanism and circumvention in lung cancer","volume":"96","author":"Zhang","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2025.118288_bib9","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/cbdd.13758","article-title":"Overcoming vincristine resistance in cancer: computational design and discovery of piperine-inspired P-glycoprotein inhibitors","volume":"97","author":"Syed","year":"2021","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2025.118288_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116543","article-title":"Dual-target inhibitors of colchicine binding site for cancer treatment","volume":"274","author":"Lu","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118288_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.216046","article-title":"SB226, an inhibitor of tubulin polymerization, inhibits paclitaxel-resistant melanoma growth and spontaneous metastasis","volume":"555","author":"Deng","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejmech.2025.118288_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114641","article-title":"C118P, a novel microtubule inhibitor with anti-angiogenic and vascular disrupting activities, exerts anti-tumor effects against hepatocellular carcinoma","volume":"190","author":"Yang","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118288_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/ph13010008","article-title":"Colchicine-binding site inhibitors from chemistry to clinic: a review","volume":"13","author":"McLoughlin","year":"2020","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2025.118288_bib14","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1126\/science.1230582","article-title":"Molecular mechanism of action of microtubule-stabilizing anticancer agents","volume":"339","author":"Prota","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2025.118288_bib15","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/febs.13555","article-title":"Structures of a diverse set of colchicine binding site inhibitors in complex with tubulin provide a rationale for drug discovery","volume":"283","author":"Wang","year":"2016","journal-title":"FEBS J."},{"key":"10.1016\/j.ejmech.2025.118288_bib16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejmech.2014.09.051","article-title":"Recent developments in tubulin polymerization inhibitors: an overview","volume":"87","author":"Kaur","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118288_bib17","doi-asserted-by":"crossref","first-page":"5865","DOI":"10.1158\/0008-5472.CAN-07-0127","article-title":"MPC-6827: a small-molecule inhibitor of microtubule formation that is not a substrate for multidrug resistance pumps","volume":"67","author":"Kasibhatla","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2025.118288_bib18","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1634\/theoncologist.2010-0432","article-title":"Cardiovascular toxicity profiles of vascular-disrupting agents","volume":"16","author":"Subbiah","year":"2011","journal-title":"Oncologist"},{"key":"10.1016\/j.ejmech.2025.118288_bib19","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1038\/s41598-022-05958-6","article-title":"Synthesis and characterization of novel combretastatin analogues of 1, 1-diaryl vinyl sulfones, with antiproliferative potential via in-silico and in-vitro studies","volume":"12","author":"Egharevba","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2025.118288_bib20","doi-asserted-by":"crossref","DOI":"10.1111\/bjh.16629","article-title":"Safety, feasibility and preliminary efficacy of single agent combretastatin A1 diphosphate (OXi4503) in patients with relapsed or refractory acute myeloid leukemia or myelodysplastic syndromes","volume":"189","author":"Cogle","year":"2020","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ejmech.2025.118288_bib21","first-page":"1445","article-title":"A phase I trial of BNC105P and ibrutinib in patients with relapsed\/refractory chronic lymphocytic leukemia","volume":"3","author":"Pooler","year":"2022","journal-title":"EJH"},{"key":"10.1016\/j.ejmech.2025.118288_bib22","doi-asserted-by":"crossref","first-page":"160","DOI":"10.2478\/aiht-2019-70-3258","article-title":"An overview of microtubule targeting agents for cancer therapy","volume":"70","author":"Karahalil","year":"2019","journal-title":"Arh. Hig. Rada Toksikol."},{"key":"10.1016\/j.ejmech.2025.118288_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111679","article-title":"Design and synthesis of (2-(phenylamino)thieno[3,2-d]pyrimidin-4-yl)(3,4,5-trimethoxyphenyl)methanone analogues as potent anti-tubulin polymerization agents","volume":"183","author":"Tian","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118288_bib24","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1002\/jcb.29342","article-title":"Combretastatin analogues in cancer biology: a prospective view","volume":"121","author":"Sherbet","year":"2020","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.ejmech.2025.118288_bib25","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2023.2295241","article-title":"Discovery of novel and potent dual-targeting AXL\/HDAC2 inhibitors for colorectal cancer treatment via structure-based pharmacophore modelling, virtual screening, and molecular docking, molecular dynamics simulation studies, and biological evaluation","volume":"39","author":"Qiao","year":"2024","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118288_bib26","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1126\/science.287.5453.646","article-title":"Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells","volume":"287","author":"Hazuda","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2025.118288_bib27","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.sajb.2021.11.033","article-title":"Identification of papain-like protease inhibitors of SARS CoV-2 through HTVS, molecular docking, MMGBSA and molecular dynamics approach","volume":"151","author":"Jupudi","year":"2022","journal-title":"South Afr. J. Bot."},{"key":"10.1016\/j.ejmech.2025.118288_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114766","article-title":"High throughput virtual screening (HTVS) of peptide library: technological advancement in ligand discovery","volume":"243","author":"Tripathi","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118288_bib29","article-title":"Optimal decision-making in high-throughput virtual screening pipelines","volume":"4","author":"Woo","year":"2023","journal-title":"Patterns (N Y)"},{"key":"10.1016\/j.ejmech.2025.118288_bib30","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.drudis.2021.09.007","article-title":"Machine-learning methods for ligand-protein molecular docking","volume":"27","author":"Crampon","year":"2022","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2025.118288_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2021.118644","article-title":"Application of molecular docking in elaborating molecular mechanisms and interactions of supramolecular cyclodextrin","volume":"276","author":"Li","year":"2022","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ejmech.2025.118288_bib32","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1021\/acs.jcim.6b00443","article-title":"Docking of macrocycles: comparing rigid and flexible docking in glide","volume":"57","author":"Alogheli","year":"2017","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2025.118288_bib33","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118288_bib34","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1021\/ci1000407","article-title":"Virtual fragment docking by glide: a validation study on 190 protein-fragment complexes","volume":"50","author":"S\u00e1ndor","year":"2010","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2025.118288_bib35","doi-asserted-by":"crossref","first-page":"9018","DOI":"10.1021\/acs.jctc.3c00943","article-title":"Encoding molecular docking for quantum computers","volume":"19","author":"Zha","year":"2023","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.ejmech.2025.118288_bib36","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.drudis.2019.03.015","article-title":"ADMET modeling approaches in drug discovery","volume":"24","author":"Ferreira","year":"2019","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2025.118288_bib37","doi-asserted-by":"crossref","first-page":"W5","DOI":"10.1093\/nar\/gkab255","article-title":"ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties","volume":"49","author":"Xiong","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2025.118288_bib38","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.tips.2020.04.001","article-title":"Structure-based virtual screening accelerates GPCR drug discovery","volume":"41","author":"Liu","year":"2020","journal-title":"Trends Pharmacol. Sci."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425010530?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425010530?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T22:58:17Z","timestamp":1773269897000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425010530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":38,"alternative-id":["S0223523425010530"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118288","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure-guided design of potent tetrazolo[1,5-a]pyrimidine-based tubulin inhibitors with in vivo antitumor activity","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118288","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118288"}}